{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:17:57Z","timestamp":1790371077448,"version":"4.1.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,30]]},"DOI":"10.7759\/cureus.87066","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T01:18:42Z","timestamp":1751332722000},"source":"Crossref","is-referenced-by-count":2,"title":["An Unusual Case of Acute Epstein-Barr Virus Hepatitis Presenting as Severe Cholestatic Liver Disease Inducing Hemophagocytic Lymphohistiocytosis in a Young Adult: A Case Report"],"prefix":"10.7759","author":[{"given":"Harpreet S","family":"Dosanjh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Primala K","family":"Dosanjh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harendra","family":"Ipalawatte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zain","family":"Mehdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202211_30395","article-title":"Oxidative stress and viral Infections: rationale, experiences, and perspectives on N-acetylcysteine","volume":"26","author":"Santus P","year":"2022","unstructured":"Santus P, Danzo F, Zuffi A, Pini S, Saad M, Visconti A, Radovanovic D. Oxidative stress and viral Infections: rationale, experiences, and perspectives on N-acetylcysteine. Eur Rev Med Pharmacol Sci. 2022, 26:8582-90. 10.26355\/eurrev_202211_30395","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2010.10.080","article-title":"N-acetylcysteine attenuates dimethylnitrosamine induced oxidative stress in rats","volume":"654","author":"Sathish P","year":"2011","unstructured":"Sathish P, Paramasivan V, Palani V, Sivanesan K. N-acetylcysteine attenuates dimethylnitrosamine induced oxidative stress in rats. Eur J Pharmacol. 2011, 654:181-6. 10.1016\/j.ejphar.2010.10.080","journal-title":"Eur J Pharmacol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12386","article-title":"Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens","volume":"162","author":"Chellapandian D","year":"2013","unstructured":"Chellapandian D, Das R, Zelley K, Wiener SJ, Zhao H, Teachey DT, Nichols KE. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens. Br J Haematol. 2013, 162:376-82. 10.1111\/bjh.12386","journal-title":"Br J Haematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2018-0208-RA","article-title":"Epstein-Barr virus hepatitis: a review of clinicopathologic features and differential diagnosis","volume":"142","author":"Schechter S","year":"2018","unstructured":"Schechter S, Lamps L. Epstein-Barr virus hepatitis: a review of clinicopathologic features and differential diagnosis. Arch Pathol Lab Med. 2018, 142:1191-5. 10.5858\/arpa.2018-0208-RA","journal-title":"Arch Pathol Lab Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2022.11.009","article-title":"N-acetylcysteine for prevention and treatment of COVID-19: current state of evidence and future directions","volume":"15","author":"Izquierdo-Alonso JL","year":"2022","unstructured":"Izquierdo-Alonso JL, P\u00e9rez-Rial S, Rivera CG, Peces-Barba G. N-acetylcysteine for prevention and treatment of COVID-19: current state of evidence and future directions. J Infect Public Health. 2022, 15:1477-83. 10.1016\/j.jiph.2022.11.009","journal-title":"J Infect Public Health"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12071316","article-title":"N-acetylcysteine pharmacology and applications in rare diseases-repurposing an old antioxidant","volume":"12","author":"Sahasrabudhe SA","year":"2023","unstructured":"Sahasrabudhe SA, Terluk MR, Kartha RV. N-acetylcysteine pharmacology and applications in rare diseases-repurposing an old antioxidant. Antioxidants (Basel). 2023, 12:1316. 10.3390\/antiox12071316","journal-title":"Antioxidants (Basel)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189167","article-title":"N-acetylcysteine (NAC) ameliorates Epstein-Barr virus latent membrane protein 1 induced chronic inflammation","volume":"12","author":"Gao X","year":"2017","unstructured":"Gao X, Lampraki EM, Al-Khalidi S, Qureshi MA, Desai R, Wilson JB. N-acetylcysteine (NAC) ameliorates Epstein-Barr virus latent membrane protein 1 induced chronic inflammation. PLoS One. 2017, 12:e0189167. 10.1371\/journal.pone.0189167","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-278127","article-title":"How I treat hemophagocytic lymphohistiocytosis","volume":"118","author":"Jordan MB","year":"2011","unstructured":"Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL. How I treat hemophagocytic lymphohistiocytosis. Blood. 2011, 118:4041-52. 10.1182\/blood-2011-03-278127","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.33175","article-title":"The role of immune mechanisms, inflammatory pathways, and macrophage activation syndrome in the pathogenesis of hemophagocytic lymphohistiocytosis","volume":"14","author":"Bseiso O","year":"2022","unstructured":"Bseiso O, Zahdeh A, Isayed O, Mahagna S, Bseiso A. The role of immune mechanisms, inflammatory pathways, and macrophage activation syndrome in the pathogenesis of hemophagocytic lymphohistiocytosis. Cureus. 2022, 14:e33175. 10.7759\/cureus.33175","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter JI","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, et al.. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007, 48:124-31. 10.1002\/pbc.21039","journal-title":"Pediatr Blood Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(82)90057-2","article-title":"Perspectives on interactions of acyclovir with Epstein-Barr and other herpes viruses","volume":"73","author":"Pagano JS","year":"1982","unstructured":"Pagano JS, Datta AK. Perspectives on interactions of acyclovir with Epstein-Barr and other herpes viruses. Am J Med. 1982, 73:18-26. 10.1016\/0002-9343(82)90057-2","journal-title":"Am J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/367653-an-unusual-case-of-acute-epstein-barr-virus-hepatitis-presenting-as-severe-cholestatic-liver-disease-inducing-hemophagocytic-lymphohistiocytosis-in-a-young-adult-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T01:18:43Z","timestamp":1751332723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/367653-an-unusual-case-of-acute-epstein-barr-virus-hepatitis-presenting-as-severe-cholestatic-liver-disease-inducing-hemophagocytic-lymphohistiocytosis-in-a-young-adult-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.87066","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,30]]}}}